Verde Science adds Shantesh Hede, Ph.D As Director of Product Development
ACCESSWIRE - 2 hrs 11 mins ago
LAS VEGAS, NV / ACCESSWIRE / April 10, 2015 / (PINKSHEETS:VRCI) Verde Science, Inc., a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients needs for a wide range of medical conditions, is pleased to announce the addition of Shantesh Hede, Ph.D. as Director of Product Development. Dr. Hede will be based in Mumbai, India and will direct Verde Science's R&D programs on-site with Verde's Research and Development partner, the Institute of Chemical Technology. He earned a Ph.D. in Bioengineering Systems from the MIT Portugal Program, a Master of Engineering Management from Duke University, and a Bachelors in Pharmaceutical Sciences from the Institute of Chemical Technology.
Verde Science Signs Research and Development Pact with Institute Of Chemical Technology
ACCESSWIRE - Wed Apr 08, 6:15PM CDT
LAS VEGAS, NV / ACCESSWIRE / April 8, 2015 / (PINKSHEETS: VRCI) Verde Science, Inc., a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients needs for a wide range of medical conditions, is pleased to announce the execution of a definitive Research and Development Agreement with the Institute of Chemical Technology of Mumbai, India. Under the terms of the agreement Verde Science researchers and faculty and staff of the University will cooperate on original research with the goal of identifying and developing novel pharmaceutical formulations derived from the marijuana plant for the treatment of specific medical issues.
Verde Science Investor Update
ACCESSWIRE - Fri Mar 13, 8:00AM CDT
LAS VEGAS, NV / ACCESSWIRE / March 13, 2015 / Verde Science, Inc., (PINKSHEETS:VRCI) a Medical Research and Development Company focused on developing effective treatments for emerging and contemporary health issues, with an initial focus on Medical Marijuana is pleased to update shareholders and investors regarding significant developments in the Medical Marijuana R&D arena.
53 Marijuana Stocks - A Post-Mortem: Part III And Epilogue
Anthony Cataldo - at Seeking Alpha - Thu Mar 05, 2:25PM CST
VPCO: 0.77 (-0.01)
12 More Marijuana Stocks To Avoid - Part II
Anthony Cataldo - at Seeking Alpha - Thu Feb 19, 8:37AM CST
News Release Verde Science Pursuing Development of Promising Point-Of-Care Ebola Screening Test
ACCESSWIRE - Mon Nov 10, 8:08AM CST
Image: https://www.baystreet.ca/uploads/verde.jpg
Verde Science and Sterkem Group Sign Pharmaceutical Development Agreement
ACCESSWIRE - Thu Nov 06, 8:01AM CST
Image: https://www.baystreet.ca/uploads/eyukuVRCI.png
News Release Verde Science R
ACCESSWIRE - Tue Nov 04, 5:00AM CST
Verde Science R&D Team Ready To Move Forward With Design Of Research Plan
Verde Science Appoints Chief Technology Officer
ACCESSWIRE - Wed Oct 22, 8:03AM CDT
Image: https://www.baystreet.ca/uploads/Verde-Scienc...-Logo1.png
Verde Science Strengthens Scientific Team
ACCESSWIRE - Thu Oct 02, 8:01AM CDT
Image: https://www.baystreet.ca/uploads/Verde-Scienc...-Logo1.png
ID Global Corporation Seeks Strategic Partnership with Verde Science, Inc.
PR Newswire - Wed Oct 01, 9:47AM CDT
ID Global Corp. (OTC: IDGC) is pleased to announce that it has signed a binding Memorandum of Understanding (MOU) with Verde Science, Inc. (OTCBB:VRCI), a Medical Marijuana Research and Development Company with particular expertise in Aeroponic Growing Systems, to begin due-diligence towards a joint venture (Exclusive or non-exclusive) whereby IDGC will provide assistance in raising capital, business advisory services and/or merger discussions.
Verde Science Forms R and D Alliance
ACCESSWIRE - Tue Sep 23, 10:14AM CDT
Richmond, BC / ACCESSWIRE / September 23, 2014 / Verde Science, Inc., (OTCQB: VRCI) a Medical Marijuana Research and Development Company with particular expertise in Aeroponic Growing Systems for the production of pure, efficacious Medical Marajuana, is pleased to announce a Research and Development Alliance with a Mumbai, India based pharmaceutical company that has a record of significant success in the development of novel medical treatment compounds. This new relationship will allow Verde to launch immediately on its THC Pharmaceutical Development Program, and accelerate its R and D operations by about one year. Without this important alliance Verde would have experienced unnecessary delays as it waited for its Research and Development License in Canada. According to Harp Sangha, Verde's Chairman and CEO, "Now we can immediately access the vast treasure of our Indian partner's intellectual capital and tap into a highly educated organization of research scientists in a cost effective manner."
Verde Science to Present at Aegis Capital Conference
Newsfile Corp - Thu Sep 11, 11:08AM CDT
full story)
Verde Science, Inc. Announces the Appointment of Mr. Bradley J. Dixon, J.D. to the Board of Directors
Marketwire - Wed Jun 18, 1:39PM CDT
Verde Science, Inc. (OTCQB: VRCI) is pleased to announce the appointment of Bradley J. Dixon, J.D. to the Board of Directors. Mr. Dixon is a trial attorney and partner in the Boise, Idaho office of Stoel Rives, LLP, which has locations throughout the northwest and California. Mr. Dixon is ranked by Chambers and Partners and was named in the 2013 Mountain States Directory of Super Lawyers. He has a wide range of litigation experience, which includes Agricultural, Natural Resources, Labor and Employment, and Product Liability cases. Mr. Dixon's trial experience representing clients through complex litigation on a broad range of disputes including complex commercial litigation, employment, insurance coverage, products liability, title insurance, foreclosure and bankruptcy trial practice, as well his governmental affairs service experience meshes well with the future needs of Verde Science.
Verde Science, Inc. Announces Appointment of Mr. Ken Berscht as Chief Executive Officer
Marketwire - Mon Jun 16, 8:02AM CDT
Verde Science, Inc. (OTCBB: VRCI) Board of Directors of is pleased to announce the appointment of Mr. Ken Berscht to the position of CEO. The Board of Directors welcomes Ken with great enthusiasm and believe they have found a dynamic and engaging leader to guide Verde through the maze of regulatory and financial hurdles in this nascent business opportunity. Mr. Berscht stated, "I am honored by the opportunity to lead Verde Science as the medical marijuana space is undergoing such a fundamental transfiguration."